[1] LÉAUTÉ-LABRÈZE C, DE LA ROQUE E D, HUBICHE T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med,2008,358(24):2649-2651. doi:  10.1056/NEJMc0708819
[2] SCHIESTL C, NEUHAUS K, ZOLLER S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas[J]. Eur J Pediatr,2011,170(4):493-501. doi:  10.1007/s00431-010-1324-2
[3] CHUNG H, KIM J, UM J Y, et al. Self-assembled "nanocubicle" as a carrier for peroral insulin delivery[J]. Diabetologia,2002,45(3):448-451. doi:  10.1007/s00125-001-0751-z
[4] BENDER J, ERICSON M B, MERCLIN N, et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy[J]. J Control Release,2005,106(3):350-360. doi:  10.1016/j.jconrel.2005.05.010
[5] EVENBRATT H, JONSSON C, FAERGEMANN J, et al. In vivo study of an instantly formed lipid-water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate[J]. Int J Pharm,2013,452(1-2):270-275. doi:  10.1016/j.ijpharm.2013.05.047
[6] Aindrilla S D, Harsiddhi M C, Kisan R J, et al. Cubosomes: innovative nanostructures for drug delivery[J]. Current Drug Delivery,2016,13:482-493. doi:  10.2174/1567201812666150224114751
[7] 曾令军, 房盛楠, 张灵娜, 等. 盐酸普萘洛尔立方液晶纳米粒的制备及体外评价[J]. 中国药师, 2020, 23(6):1094-1101.